Recuro is an integrated digital health solution that evolves healthcare from a reactive, disease-focused model to a personalized, proactive system.
Recuro delivers value throughout the healthcare ecosystem with an integrated digital health solution that transitions the U.S. healthcare system from a reactive, disease focused model to a population health, outcomes approach.
Recuro Health was founded in 2021 by Michael Gorton. The company is headquartered in Dallas, Texas.
Recuro’s virtual health platform consists of a curated suite of digital solutions – from primary care and behavioural health to at-home testing and genetic screening.
Recuro’s solutions can be tailored to meet the needs of any population, allowing patients to engage with physicians, receive more personalised care and monitor their own health – no matter their location or circumstance.
Recuro, with streamlined information exchange between primary care and behavioral health teams as well as testing and screening tools, its virtual health platform enables the delivery of coordinated, holistic care that ultimately results in better outcomes at a lower cost.
Recuro has raised $15M in a Series A funding on Aug 25, 2021. The round was led by ARCH Venture Partners, with participations from OLSF Ventures, Cortado Ventures, 1843 Capital and Sage Venture Partners.